Invitrogen

Human CCM2L (aa 320-414) Control Fragment Recombinant Protein

Product Details

RP-107789

Applications

Tested Dilution

Publications

Control (Ctrl)

Assay-dependent

Blocking Assay (BLOCK)

Assay-dependent

Product Specifications

Species

Human

Expression System

E. coli

Amino acid sequence

LICQVFQIIYGDQSIECVDRAGYHYTSTPERPWLCSRSESCHTDGTYAYDADFSCCSSFNGSQDTFEACYSGTSTPSFHGSHCSGSDHSSLGLEQ

Tag

His-ABP-tag

Class

Recombinant

Type

Protein

Purity

>80% by SDS-PAGE and Coomassie blue staining

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

≥5.0 mg/mL

Purification

purified

Storage buffer

PBS/1M urea, pH 7.4

Contains

no preservative

Storage conditions

-20°C, Avoid Freeze/Thaw Cycles

Product Specific Information

Highest antigen sequence indentity to the following orthologs: Mouse (35%), Rat (35%).

This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-67142. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.

Target Information

CCM2L gene ontology annotations related to this gene include cardiac atrium morphogenesis; cardiac muscle tissue growth; negative regulation of homotypic cell-cell adhesion; negative regulation of protein binding; positive regulation of fibroblast growth factor production; ventricular trabecula myocardium morphogenesis; wound healing.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

References (0)

Have you cited this product in a publication?

Let us know so we can reference it here.

Cite this product

Bioinformatics

Protein Aliases: CCM2-like; cerebral cavernous malformation 2-like; Cerebral cavernous malformations 2 protein-like